CN106509760A - Royal jelly buccal tablets and preparation method thereof - Google Patents
Royal jelly buccal tablets and preparation method thereof Download PDFInfo
- Publication number
- CN106509760A CN106509760A CN201610830560.9A CN201610830560A CN106509760A CN 106509760 A CN106509760 A CN 106509760A CN 201610830560 A CN201610830560 A CN 201610830560A CN 106509760 A CN106509760 A CN 106509760A
- Authority
- CN
- China
- Prior art keywords
- royal jelly
- parts
- lac regis
- regis apis
- propolis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940109850 royal jelly Drugs 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 239000006189 buccal tablet Substances 0.000 title abstract 5
- 239000002994 raw material Substances 0.000 claims abstract description 29
- 241000241413 Propolis Species 0.000 claims abstract description 17
- 229940069949 propolis Drugs 0.000 claims abstract description 17
- 210000000582 semen Anatomy 0.000 claims abstract description 17
- 239000007937 lozenge Substances 0.000 claims description 32
- 239000000843 powder Substances 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 12
- 239000005030 aluminium foil Substances 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000005022 packaging material Substances 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 6
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 6
- 210000003734 kidney Anatomy 0.000 abstract description 14
- 210000004185 liver Anatomy 0.000 abstract description 13
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 8
- 210000004072 lung Anatomy 0.000 abstract description 8
- 210000000232 gallbladder Anatomy 0.000 abstract description 4
- 230000003014 reinforcing effect Effects 0.000 abstract description 2
- 244000298479 Cichorium intybus Species 0.000 abstract 1
- 235000007542 Cichorium intybus Nutrition 0.000 abstract 1
- 206010039424 Salivary hypersecretion Diseases 0.000 abstract 1
- 235000004879 dioscorea Nutrition 0.000 abstract 1
- 230000035622 drinking Effects 0.000 abstract 1
- 208000026451 salivation Diseases 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 241000256836 Apis Species 0.000 description 39
- 230000007812 deficiency Effects 0.000 description 8
- 241000256844 Apis mellifera Species 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 6
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 6
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 5
- 235000017491 Bambusa tulda Nutrition 0.000 description 5
- 241001330002 Bambuseae Species 0.000 description 5
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 5
- 239000011425 bamboo Substances 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 239000010977 jade Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010019668 Hepatic fibrosis Diseases 0.000 description 4
- 230000004913 activation Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 210000003800 pharynx Anatomy 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 229940123457 Free radical scavenger Drugs 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- QHBZHVUGQROELI-SOFGYWHQSA-N (E)-10-hydroxydec-2-enoic acid Chemical compound OCCCCCCC\C=C\C(O)=O QHBZHVUGQROELI-SOFGYWHQSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 1
- 241000256837 Apidae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101150071146 COX2 gene Proteins 0.000 description 1
- 101100114534 Caenorhabditis elegans ctc-2 gene Proteins 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- -1 Flavone compound Chemical class 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 101150000187 PTGS2 gene Proteins 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 1
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- QHBZHVUGQROELI-UHFFFAOYSA-N Royal Jelly acid Natural products OCCCCCCCC=CC(O)=O QHBZHVUGQROELI-UHFFFAOYSA-N 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000013507 chronic prostatitis Diseases 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Substances N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 1
- 208000018934 joint symptom Diseases 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention discloses royal jelly buccal tablets. The royal jelly buccal tablets are prepared from the following raw materials: royal jelly, propolis, semen cuscutae, fructus ligustri lucidi, Chinese yams, cichorium intybus, fructus schizandrae and radix polygonati officinalis. The prepared royal jelly buccal tablets solve the problem that the powdery royal jelly is easy to cause throat discomfort during drinking, contain traditional Chinese medicines, and have effects of reinforcing liver and kidney, promoting salivation and benefiting lungs, clearing liver and benefiting gallbladder, nourishing yin and moistening dryness, etc. Besides, the preparation technology is simple, the cost is reduced and the royal jelly buccal tablets are more acceptable by public.
Description
Technical field
The invention belongs to food technology field, and in particular to a kind of royal jelly lozenge and preparation method thereof.
Background technology
Lac regis apis are 5～15 age in days worker bee lingual glands and the milky secreted by upper palatine gland or faint yellow emulsion liquid, are honeybees
King larva whole period of development and unique food of drone larva early stage, similar to the milk of mammal, also known as Lac regis apiss, king
Slurry, Lac regis apis.Attention and attention to Lac regis apis, is that the young honeybee for being found that feed Mel can only grow up to worker bee first, and the life-span is general
It is 30～40 days, most long 7～8 months, and the young honeybee of feed Lac regis apis can grow up to queen bee, life-span length up to 3～5 years, this phenomenon
Prompting food of the people by the use of Lac regis apis as life lengthening, but to its property and the mechanism of action and do not know about.By 1888, moral
State's chemist A Von Planta first component to Lac regis apis of ability carries out general Journal of Sex Research, and so far people have started discussion honeybee
The profoundness of royal jelly, but Lac regis apis are carried out including comprehensive research of biology, chemical pharmacology and clinical experiment, or nearest tens
Year is inchoate, and people also do not study clear completely to some the micro bioactive substances in Lac regis apis so far.At present, really
About 9 big class of fixed functional factor：They are peptides and protein-based；Functional sweetener；Functional grease；Free radical scavenger；
Vitamin；Active trace element；Active polysaccharide；Flavone compound and the Tiny ecosystem factor such as lactic acid bacteria etc..Grinding according to people
Study carefully discovery, containing these abundant functional factors in Lac regis apis, have extremely strong alimentary health-care function and medical function to the mankind.
Modern study shows：Lac regis apis can mitigate hepatocellular damaging action in the ALD courses of disease, to the liver group after damage
The effect for promoting regeneration is woven with, its mechanism of action may be by reducing or suppressing the generation of COX-2, it is to avoid excessive inflammatory is anti-
Should, mitigation mitochondrion and lipid peroxidation injury is reached, so as to reduce the level of serum AST and ALT；Lac regis apis are reduced
Expression of the TNF-α in hepatocyte, and TNF-α has mediated hepatocellular inflammatory reaction, immunoreation, liver as inflammatory factor
Various pathology and the physiological activity such as apoptosis and amplification hepatic fibrosis.The reason for analysing royal jelly TNF-α is reduced is probably honeybee
Royal jelly is natural oxygen free radical scavenger, it is possible to reduce the activation of the nuclear factor that ROS causes, so as to reduce by its regulation and control
TNF-α gene expression.Lac regis apis can press down the expression of COX -2 and TNF-α in the forming process of alcoholic liver disease, right
Alcoholic liver injury has certain protective effect.Lac regis apis also refer to the hepatic fibrosiss serology of CC14 hepatic fibrosis ratses
Mark and hepatic pathology morphology are respectively provided with significant improvement result, but change to having formed the liver tissue fibrosis after hepatic fibrosis
It is apt to not substantially, its possible mechanism is that Lac regis apis can improve the inflammation of hepatic tissue, reduce the synthesis of ECM and suppress dividing for TNF-α
Secrete.
As liquid royal jelly products preserve, carry and take all inconvenient, although and powdery royal jelly products customer service
The deficiency of liquid royal jelly products, but its taste is sour, puckery, usually causes throat discomfort, cough etc., thus be difficult to wide when taking
Big consumer receives.
At present, the health food for improving body immunity on market is a lot, but mainly asking of existing of these health foods
Topic is that raw material type is more, complicated process of preparation, and product cost is high, causes these products that masses cannot be allowed to receive.
The content of the invention
In order to solve the above problems, the present invention provides a kind of royal jelly lozenge and preparation method thereof.
The technical solution used in the present invention is：
A kind of royal jelly lozenge, it is by made by following raw materials according：Lac regis apis, propolis, Semen Cuscutae, Fructus Ligustri Lucidi, Rhizoma Dioscoreae, Herba Cichorii,
Fructus Schisandrae Chinensis, Rhizoma Polygonati Odorati.
A kind of royal jelly lozenge, it is prepared by the raw materials in：Lac regis apis 30-40 parts, propolis 10-20
Part, Semen Cuscutae 6-12 parts, Fructus Ligustri Lucidi 6-12 parts, Rhizoma Dioscoreae 15-30 parts, Herba Cichorii 9-18 parts, Fructus Schisandrae Chinensis 5-10 parts, Rhizoma Polygonati Odorati 6-12 parts.
A kind of preparation method of royal jelly lozenge as above：Comprise the following steps：
（1）Filter：Weigh Lac regis apis, propolis, Semen Cuscutae, Fructus Ligustri Lucidi, Rhizoma Dioscoreae, Herba Cichorii, Fructus Schisandrae Chinensis and the jade of above-mentioned weight portion
Bamboo, then removes the impurity in each raw material, then cleans, Rhizoma Dioscoreae peeling；
（2）It is dried：Each raw material after cleaning is put in vacuum freeze drier carries out vacuum freeze-drying；
（3）Crush：Dried each raw material is put into into pulverizer and is ground into powder, cross 300 mesh sieves；
（4）Stir evenly：Each material powder mixing and stirring after by crushing；
（5）Tabletting：Material powder after stirring evenly is put into tablet machine carries out tabletting, obtains royal jelly lozenge；
（6）Packaging：Royal jelly lozenge is vacuum-packed, packaging material aluminium-foil paper.
Lac regis apis have following effect：1) Lac regis apis contain acetylcholine, vegetative nerve can be made to recover normal, to treating painstaking effort
Pipe disease effect is significant；2) Lac regis apis are rich in vitamin B and high quality protein, particularly containing the royal jelly acid that sterilizing power is strong, thus are
Good medicine for cancer；3) Lac regis apis have promotion hemopoietic function effect, developmental children can be increased with hemoglobin, promote life
It is long, improve premunition；4) Lac regis apis are contained within pantothenic acid, can improve rheumatism and joint symptoms；5) Lac regis apis contain para-insulin, right
Diabetes have better effects；6) Lac regis apis can strengthen adrenal cortex function, adjust human hormone, brain cell between activation, favorably
In treatment climacteric disfunction and chronic prostatitis syndrome；7) Lac regis apis can strengthen the basis muscle power of people, make one asthenia old tissue
Activation, after clothes, appetite is good, and long spirit, complexion are good；8) peptide contained by Lac regis apis and protein-based healthy ingredient, can promote intelligence to send out
Exhibition, thus take and can improve memory；9) Lac regis apis contain proteohormone, with blood circulation whole body after clothes, contribute to skin group
Knit technical ability to rejuvenate, effect is scalded to treatment obvious；10) Lac regis apis contain plurality of inorganic salt, and glycogen can be promoted to discharge, and promote generation
Thank, thus speckle can be eliminated with beauty.
Propolis, bitter, acrid, cold.Returns spleen, stomach.Qi-restoratives for oral administration is weak, changes turbid fat, only quenches one's thirst；External removing toxic substances and promoting subsidence of swelling, convergence life
Flesh.Take orally for body void senilism, hyperlipemia, quench one's thirst；External treatment is used for chapped skin, burn and scald.
Semen Cuscutae, it is pungent, sweet, put down.Return liver, kidney, spleen channel.Liver and kidney tonifying, astringent sperm contracting urine are antiabortive, improving eyesight, antidiarrheal；External disappears
Wind speckle dispelling.For deficiency of the liver and kindey, soreness of the waist and knees, impotence and seminal emission, enuresis frequent micturition, vaginal bleeding due to deficiency of the kidney during pregnancy, frequent fetal movement, blurred vision tinnitus, spleen
Kidney deficiency is rushed down；Externally treating leucoderma.
Fructus Ligustri Lucidi, sweet, bitter, cold.Return liver and kidney channel.Nourishing the liver and kidney, improving eyesight black hair.For the hepatic and renal YIN deficiency, vertigo and tinnitus, waist
Knees soreness, early whitening of beard and hair, poor vision, Heat Diabetes, osteopyrexia and fever.
Rhizoma Dioscoreae, it is sweet, put down.Returns spleen, lung, kidney channel.Spleen reinforcing nourishing the stomach, engender liquid and benefic lung, the kidney invigorating arresting seminal emission.For spleen eating less, chronic diarrhea
Incessantly, the deficiency of the lung is breathed with cough, and emission due to deficiency of the kidney, leukorrhagia, frequent micturition, deficiency-heat are quenched one's thirst.Rhizoma Dioscoreae (parched with bran) good efficacy to suffering from a deficiency of the kidney.For spleen eating less, have loose bowels
Loose stool, leukorrhagia.
Herba Cichorii, it is slight bitter, salty, it is cool.Return liver, gallbladder, stomach.Liver heat removing function of gallbladder promoting, invigorating the stomach and promoting digestion, promoting the production of body fluid to quench thirst, inducing diuresis to remove edema.For
Jaundice due to damp-heat, lack of appetite of having a stomachache, Heat Diabetes, edema oliguria.
Fructus Schisandrae Chinensis, sour, sweet, temperature.Return lung, the heart, kidney channel.Restrain astringent or styptic treatment for spontaneous sweating, supplementing QI for promoting the production of body fluid, kidney calming.For chronic cough dyspnea due to deficiency, nocturnal emission
Spermatorrhea, enuresis frequent micturition, incessant chronic diarrhea, spontaneous sweating, injury thirst, Heat Diabetes, palpitation and insomnia.
Rhizoma Polygonati Odorati, it is sweet, it is slightly cold.Attach to the lung and stomach meridians.Nourishing YIN to relieve dryness, promoting the production of body fluid to quench thirst.For lung stomach impairment of yin, cough caused by dryness-heat, dry pharynx mouth
Yearningly, Heat Diabetes.
The invention has the beneficial effects as follows：The royal jelly lozenge that the present invention makes is solved when powdery Lac regis apis are quoted and is easily drawn
The problem of throat discomfort is played, and in the royal jelly lozenge of the present invention, contains Chinese medicine, with liver and kidney tonifying, engender liquid and benefic lung, liver heat removing
The effects such as function of gallbladder promoting, nourishing YIN to relieve dryness；And preparation process is simple, reduces cost, it is easier to allow masses to receive.
Specific embodiment
A kind of royal jelly lozenge, it is by made by following raw materials according：Lac regis apis, propolis, Semen Cuscutae, Fructus Ligustri Lucidi, Rhizoma Dioscoreae, chrysanthemum
Lettuce, Fructus Schisandrae Chinensis, Rhizoma Polygonati Odorati.
A kind of royal jelly lozenge, it is prepared by the raw materials in：Lac regis apis 30-40 parts, propolis 10-20
Part, Semen Cuscutae 6-12 parts, Fructus Ligustri Lucidi 6-12 parts, Rhizoma Dioscoreae 15-30 parts, Herba Cichorii 9-18 parts, Fructus Schisandrae Chinensis 5-10 parts, Rhizoma Polygonati Odorati 6-12 parts.
A kind of preparation method of royal jelly lozenge as above：Comprise the following steps：
（1）Filter：Weigh Lac regis apis, propolis, Semen Cuscutae, Fructus Ligustri Lucidi, Rhizoma Dioscoreae, Herba Cichorii, Fructus Schisandrae Chinensis and the jade of above-mentioned weight portion
Bamboo, then removes the impurity in each raw material, then cleans, Rhizoma Dioscoreae peeling；
（2）It is dried：Each raw material after cleaning is put in vacuum freeze drier carries out vacuum freeze-drying；
（3）Crush：Dried each raw material is put into into pulverizer and is ground into powder, cross 300 mesh sieves；
（4）Stir evenly：Each material powder mixing and stirring after by crushing；
（5）Tabletting：Material powder after stirring evenly is put into tablet machine carries out tabletting, obtains royal jelly lozenge；
（6）Packaging：Royal jelly lozenge is vacuum-packed, packaging material aluminium-foil paper.
Embodiment 1
A kind of royal jelly lozenge, it is prepared by the raw materials in：40 parts of Lac regis apis, 20 parts of propolis, Semen Cuscutae 12
Part, 12 parts of Fructus Ligustri Lucidi, 30 parts of Rhizoma Dioscoreae, 18 parts of Herba Cichorii, 10 parts of Fructus Schisandrae Chinensis, 12 parts of Rhizoma Polygonati Odorati.
A kind of preparation method of royal jelly lozenge as above：Comprise the following steps：
（1）Filter：Weigh Lac regis apis, propolis, Semen Cuscutae, Fructus Ligustri Lucidi, Rhizoma Dioscoreae, Herba Cichorii, Fructus Schisandrae Chinensis and the jade of above-mentioned weight portion
Bamboo, then removes the impurity in each raw material, then cleans, Rhizoma Dioscoreae peeling；
（2）It is dried：Each raw material after cleaning is put in vacuum freeze drier carries out vacuum freeze-drying；
（3）Crush：Dried each raw material is put into into pulverizer and is ground into powder, cross 300 mesh sieves；
（4）Stir evenly：Each material powder mixing and stirring after by crushing；
（5）Tabletting：Material powder after stirring evenly is put into tablet machine carries out tabletting, obtains royal jelly lozenge；
（6）Packaging：Royal jelly lozenge is vacuum-packed, packaging material aluminium-foil paper.
Embodiment 2
A kind of royal jelly lozenge, it is prepared by the raw materials in：30 parts of Lac regis apis, 10 parts of propolis, Semen Cuscutae 6
Part, 6 parts of Fructus Ligustri Lucidi, 15 parts of Rhizoma Dioscoreae, 9 parts of Herba Cichorii, 5 parts of Fructus Schisandrae Chinensis, 6 parts of Rhizoma Polygonati Odorati.
A kind of preparation method of royal jelly lozenge as above：Comprise the following steps：
（1）Filter：Weigh Lac regis apis, propolis, Semen Cuscutae, Fructus Ligustri Lucidi, Rhizoma Dioscoreae, Herba Cichorii, Fructus Schisandrae Chinensis and the jade of above-mentioned weight portion
Bamboo, then removes the impurity in each raw material, then cleans, Rhizoma Dioscoreae peeling；
（2）It is dried：Each raw material after cleaning is put in vacuum freeze drier carries out vacuum freeze-drying；
（3）Crush：Dried each raw material is put into into pulverizer and is ground into powder, cross 300 mesh sieves；
（4）Stir evenly：Each material powder mixing and stirring after by crushing；
（5）Tabletting：Material powder after stirring evenly is put into tablet machine carries out tabletting, obtains royal jelly lozenge；
（6）Packaging：Royal jelly lozenge is vacuum-packed, packaging material aluminium-foil paper.
Embodiment 3
A kind of royal jelly lozenge, it is prepared by the raw materials in：35 parts of Lac regis apis, 15 parts of propolis, Semen Cuscutae 9
Part, 9 parts of Fructus Ligustri Lucidi, 22 parts of Rhizoma Dioscoreae, 13 parts of Herba Cichorii, 7 parts of Fructus Schisandrae Chinensis, 9 parts of Rhizoma Polygonati Odorati.
A kind of preparation method of royal jelly lozenge as above：Comprise the following steps：
（1）Filter：Weigh Lac regis apis, propolis, Semen Cuscutae, Fructus Ligustri Lucidi, Rhizoma Dioscoreae, Herba Cichorii, Fructus Schisandrae Chinensis and the jade of above-mentioned weight portion
Bamboo, then removes the impurity in each raw material, then cleans, Rhizoma Dioscoreae peeling；
（2）It is dried：Each raw material after cleaning is put in vacuum freeze drier carries out vacuum freeze-drying；
（3）Crush：Dried each raw material is put into into pulverizer and is ground into powder, cross 300 mesh sieves；
（4）Stir evenly：Each material powder mixing and stirring after by crushing；
（5）Tabletting：Material powder after stirring evenly is put into tablet machine carries out tabletting, obtains royal jelly lozenge；
（6）Packaging：Royal jelly lozenge is vacuum-packed, packaging material aluminium-foil paper.
Claims (3)
1. a kind of royal jelly lozenge, it is characterised in that：It is by made by following raw materials according：Lac regis apis, propolis, Semen Cuscutae, Fructus Ligustri Lucidi
Son, Rhizoma Dioscoreae, Herba Cichorii, Fructus Schisandrae Chinensis, Rhizoma Polygonati Odorati.
2. a kind of royal jelly lozenge according to claim 1, it is characterised in that：It is to be prepared by the raw materials in
's：Lac regis apis 30-40 parts, propolis 10-20 parts, Semen Cuscutae 6-12 parts, Fructus Ligustri Lucidi 6-12 parts, Rhizoma Dioscoreae 15-30 parts, Herba Cichorii 9-18
Part, Fructus Schisandrae Chinensis 5-10 parts, Rhizoma Polygonati Odorati 6-12 parts.
3. a kind of preparation method of royal jelly lozenge as claimed in claim 2：It is characterized in that：Comprise the following steps：
（1）Filter：Lac regis apis, propolis, Semen Cuscutae, Fructus Ligustri Lucidi, Rhizoma Dioscoreae, Herba Cichorii, Fructus Schisandrae Chinensis and the Rhizoma Polygonati Odorati of above-mentioned weight portion is weighed,
Then the impurity in each raw material is removed, is then cleaned, Rhizoma Dioscoreae peeling；
（2）It is dried：Each raw material after cleaning is put in vacuum freeze drier carries out vacuum freeze-drying；
（3）Crush：Dried each raw material is put into into pulverizer and is ground into powder, cross 300 mesh sieves；
（4）Stir evenly：Each material powder mixing and stirring after by crushing；
（5）Tabletting：Material powder after stirring evenly is put into tablet machine carries out tabletting, obtains royal jelly lozenge；
（6）Packaging：Royal jelly lozenge is vacuum-packed, packaging material aluminium-foil paper.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610830560.9A CN106509760A (en) | 2016-09-19 | 2016-09-19 | Royal jelly buccal tablets and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610830560.9A CN106509760A (en) | 2016-09-19 | 2016-09-19 | Royal jelly buccal tablets and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106509760A true CN106509760A (en) | 2017-03-22 |
Family
ID=58343804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610830560.9A Pending CN106509760A (en) | 2016-09-19 | 2016-09-19 | Royal jelly buccal tablets and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106509760A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110547420A (en) * | 2018-05-30 | 2019-12-10 | 福州大学 | Royal jelly enzyme buccal tablet and preparation method thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102125196A (en) * | 2010-01-20 | 2011-07-20 | 陈维太 | Bee product formulation |
| CN102440384A (en) * | 2011-11-14 | 2012-05-09 | 哈药集团三精制药股份有限公司 | Ginseng and royal jelly composite capsule and preparation method thereof |
| CN103238771A (en) * | 2012-02-03 | 2013-08-14 | 丁徽 | Bee health product |
| CN103704552A (en) * | 2013-12-15 | 2014-04-09 | 甘肃景卉蜂业有限责任公司 | Honey pollen paste and preparation method thereof |
| CN103719659A (en) * | 2013-12-15 | 2014-04-16 | 甘肃景卉蜂业有限责任公司 | Royal jelly honey and preparation method thereof |
| CN105395677A (en) * | 2015-11-20 | 2016-03-16 | 武汉思维特食品有限公司 | Royal jelly, propolis and Chinese magnoliavine fruit capsule and preparation method thereof |
| CN105725143A (en) * | 2016-02-02 | 2016-07-06 | 桐城市永锦建筑工程有限公司 | Royal jelly lozenge |
-
2016
- 2016-09-19 CN CN201610830560.9A patent/CN106509760A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102125196A (en) * | 2010-01-20 | 2011-07-20 | 陈维太 | Bee product formulation |
| CN102440384A (en) * | 2011-11-14 | 2012-05-09 | 哈药集团三精制药股份有限公司 | Ginseng and royal jelly composite capsule and preparation method thereof |
| CN103238771A (en) * | 2012-02-03 | 2013-08-14 | 丁徽 | Bee health product |
| CN103704552A (en) * | 2013-12-15 | 2014-04-09 | 甘肃景卉蜂业有限责任公司 | Honey pollen paste and preparation method thereof |
| CN103719659A (en) * | 2013-12-15 | 2014-04-16 | 甘肃景卉蜂业有限责任公司 | Royal jelly honey and preparation method thereof |
| CN105395677A (en) * | 2015-11-20 | 2016-03-16 | 武汉思维特食品有限公司 | Royal jelly, propolis and Chinese magnoliavine fruit capsule and preparation method thereof |
| CN105725143A (en) * | 2016-02-02 | 2016-07-06 | 桐城市永锦建筑工程有限公司 | Royal jelly lozenge |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110547420A (en) * | 2018-05-30 | 2019-12-10 | 福州大学 | Royal jelly enzyme buccal tablet and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102091258B (en) | Chinese medicinal composition for dispelling scars and preparation method thereof | |
| CN103520572B (en) | A kind of Chinese medicine composition being used for the treatment of atopic dermatitis and preparation method thereof | |
| CN104873763A (en) | Health-care product for conditioning Qi deficiency constitution | |
| CN107737268A (en) | Soothing the liver dissipating bind and spot-removing beautifying face herbal paste and preparation method thereof | |
| CN104666896A (en) | Orally-taken medicine for treating alopecia seborrhoeica and preparation method for orally-taken medicine | |
| CN106606550A (en) | Traditional Chinese medicine composition capable of moistening intestines and relaxing bowels and preparation method thereof, and health food | |
| CN101164600A (en) | Medicine for treating acne and whelk | |
| CN104757536A (en) | Brassica rapa health-care product | |
| CN103385329B (en) | Chinese herbal medicine brewing tea for treating old people constipation | |
| CN102805834B (en) | Drug for curing gastritis and preparation method thereof | |
| CN102579818B (en) | Traditional Tibetan medicine composition, preparation method thereof and application | |
| CN106509760A (en) | Royal jelly buccal tablets and preparation method thereof | |
| CN113925172A (en) | Giant salamander peptide nutritional composition suitable for children | |
| CN103330259A (en) | Food composition with functions of nourishing yin, moisturizing lung and clearing way heat and preparation method thereof | |
| CN106540083A (en) | A kind of preparation method of Fructus Momordicae charantiae Rhizoma Coptidis tea | |
| CN104147186A (en) | Rose essential oil hydrogel plaster and preparation method thereof | |
| CN103860787A (en) | External traditional Chinese medicament containing astarte effective component and used for treating acne | |
| CN106262801A (en) | A kind of nutrient formulation nano-particle preventing and treating thrombophlebitis and preparation processing method | |
| CN106359737A (en) | Honey black tea and making method thereof | |
| CN105362907A (en) | Effervescent tablet for treating breast cyst and preparation method of effervescent tablet for treating breast cyst | |
| CN106165885A (en) | A kind of nutrient formulation nano-particle preventing and treating chronic superficial gastritis and preparation processing method | |
| CN106174011A (en) | A kind of nutrient formulation nano-particle preventing and treating diabetes and preparation processing method | |
| CN104857242A (en) | Spleen-invigorating and digestion-promoting preparation for treating infantile malnutrition and preparation method | |
| CN109731069A (en) | A kind of Chinese medicine composition of controlling nocturnal emission with astringent drugs mends marrow and its application | |
| CN103933210A (en) | Abalone-ingredient-containing traditional Chinese medicine preparation for treating epilepsia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170322 |